Hyperthermic Intrathoracic Chemoperfusion for Malignant Pleural Mesothelioma: Systematic Review and Meta-Analysis
Malignant pleural mesothelioma (MPM) is an aggressive malignancy of the pleural lining with exceptionally poor survival. Hyperthermic intrathoracic chemoperfusion (HITHOC) is commonly used with surgery in limited disease. However, data on its effect on survival are limited. In this systematic review...
Main Authors: | Tommi Järvinen, Juuso Paajanen, Ilkka Ilonen, Jari Räsänen |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2021-07-01
|
Series: | Cancers |
Subjects: | |
Online Access: | https://www.mdpi.com/2072-6694/13/14/3637 |
Similar Items
-
Hyperthermic Intrathoracic Chemotherapy (HITOC) after Cytoreductive Surgery for Pleural Malignancies—A Retrospective, Multicentre Study
by: Michael Ried, et al.
Published: (2021-09-01) -
Anaesthetic management of extra-pleural pneumonectomy and hyperthermic intrathoracic chemotherapy procedure
by: Jalaja Koppa Ramegowda, et al.
Published: (2015-01-01) -
The Excretion of Cisplatin after Hyperthermic Intrathoracic Chemotherapy
by: Christopher Larisch, et al.
Published: (2023-10-01) -
Comparison of video-assisted pleurectomy/decortication surgery plus hyperthermic intrathoracic chemotherapy with VATS talc pleurodesis for the treatment of malignant pleural mesothelioma: A pilot study
by: Marcello Migliore, et al.
Published: (2023-06-01) -
Evidence for marked underutilization of insurance billing in malignant pleural mesothelioma in Finland
by: Paulus Torkki, et al.
Published: (2021-10-01)